ATE453659T1 - Verfahren zur herstellung von 7-alpha- methylsteroide - Google Patents

Verfahren zur herstellung von 7-alpha- methylsteroide

Info

Publication number
ATE453659T1
ATE453659T1 AT03702441T AT03702441T ATE453659T1 AT E453659 T1 ATE453659 T1 AT E453659T1 AT 03702441 T AT03702441 T AT 03702441T AT 03702441 T AT03702441 T AT 03702441T AT E453659 T1 ATE453659 T1 AT E453659T1
Authority
AT
Austria
Prior art keywords
alpha
producing
methyl steroids
steroids
methyl
Prior art date
Application number
AT03702441T
Other languages
English (en)
Inventor
J Stoelwinder
M Ostendorf
Van P A M Buggenum
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of ATE453659T1 publication Critical patent/ATE453659T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0085Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
AT03702441T 2002-01-21 2003-01-14 Verfahren zur herstellung von 7-alpha- methylsteroide ATE453659T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075230 2002-01-21
PCT/EP2003/000339 WO2003059931A1 (en) 2002-01-21 2003-01-14 PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS

Publications (1)

Publication Number Publication Date
ATE453659T1 true ATE453659T1 (de) 2010-01-15

Family

ID=8185555

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03702441T ATE453659T1 (de) 2002-01-21 2003-01-14 Verfahren zur herstellung von 7-alpha- methylsteroide

Country Status (28)

Country Link
US (2) US20050090476A1 (de)
EP (1) EP1470151B1 (de)
JP (1) JP5250174B2 (de)
KR (1) KR100937179B1 (de)
CN (1) CN100372864C (de)
AR (1) AR038165A1 (de)
AT (1) ATE453659T1 (de)
AU (1) AU2003205604B8 (de)
BR (1) BRPI0306736B8 (de)
CA (1) CA2472379C (de)
DE (1) DE60330749D1 (de)
EC (1) ECSP045180A (de)
EG (1) EG23417A (de)
ES (1) ES2336439T3 (de)
HR (1) HRP20040634B1 (de)
IL (2) IL162770A0 (de)
IS (1) IS2740B (de)
MX (1) MXPA04007049A (de)
NO (1) NO327095B1 (de)
NZ (1) NZ533970A (de)
PE (1) PE20030926A1 (de)
PL (1) PL208163B1 (de)
RO (1) RO122913B1 (de)
RS (1) RS51490B (de)
RU (1) RU2305105C2 (de)
TW (1) TWI322813B (de)
WO (1) WO2003059931A1 (de)
ZA (1) ZA200405257B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10213371C1 (de) * 2002-03-21 2003-12-24 Schering Ag Verfahren zur Herstellung von 7alpha-Methylsteroiden
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
KR100716981B1 (ko) * 2004-09-30 2007-05-10 삼성전자주식회사 대중교통의 최적경로 검색방법 및 이를 이용한 휴대용 기기
JP5749261B2 (ja) * 2009-06-29 2015-07-15 メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー 3,3,5,5−テトラメチルシクロヘキサノンを調製する方法
CN111944001A (zh) * 2020-07-09 2020-11-17 浙江神洲药业有限公司 一种替勃龙的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3470216A (en) * 1966-11-29 1969-09-30 Du Pont Selected 17,17-difluoro unsaturated androstanes
FR2054527B1 (de) * 1969-07-28 1973-06-08 Roussel Uclaf
US3798213A (en) * 1971-01-25 1974-03-19 Merck & Co Inc 7 alpha-methyl-20-spiroxane-3-ones and process
DE2558088C2 (de) * 1975-12-19 1985-05-30 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten
JPS56145239A (en) * 1980-04-11 1981-11-11 Sumitomo Chem Co Ltd Novel bicyclooctane derivative and its preparation
US4298559A (en) * 1980-07-23 1981-11-03 Dow Corning Corporation High yield silicon carbide from alkylated or arylated pre-ceramic polymers
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6548491B2 (en) * 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
IL149424A (en) * 1999-12-02 2007-05-15 Organon Nv Androgens are converted to methylene at positions 15,14
WO2001058919A2 (en) * 2000-02-11 2001-08-16 Sri International Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
AU8201601A (en) * 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
US20040010138A1 (en) * 2002-03-21 2004-01-15 Schering Ag Process for the production of 7alpha-methyl steroids
US7304157B2 (en) * 2004-09-28 2007-12-04 Bristol-Myers Squibb Company Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Also Published As

Publication number Publication date
NZ533970A (en) 2005-10-28
US20050090476A1 (en) 2005-04-28
IL162770A (en) 2011-06-30
CA2472379C (en) 2010-05-25
RO122913B1 (ro) 2010-04-30
EG23417A (en) 2005-06-28
US20100204497A1 (en) 2010-08-12
CA2472379A1 (en) 2003-07-24
IL162770A0 (en) 2005-11-20
ZA200405257B (en) 2005-08-31
ECSP045180A (es) 2004-08-27
NO327095B1 (no) 2009-04-20
TWI322813B (en) 2010-04-01
JP2005519899A (ja) 2005-07-07
AU2003205604B2 (en) 2009-11-26
WO2003059931A1 (en) 2003-07-24
AU2003205604B8 (en) 2009-12-24
JP5250174B2 (ja) 2013-07-31
BR0306736A (pt) 2004-12-28
AU2003205604A1 (en) 2003-07-30
BRPI0306736B1 (pt) 2017-11-07
RS51490B (sr) 2011-04-30
RU2305105C2 (ru) 2007-08-27
DE60330749D1 (de) 2010-02-11
HRP20040634B1 (hr) 2013-07-31
EP1470151B1 (de) 2009-12-30
NO20043455L (no) 2004-08-19
KR100937179B1 (ko) 2010-01-19
MXPA04007049A (es) 2004-10-14
ES2336439T3 (es) 2010-04-13
PL371583A1 (en) 2005-06-27
TW200302731A (en) 2003-08-16
EP1470151A1 (de) 2004-10-27
PL208163B1 (pl) 2011-03-31
KR20040077727A (ko) 2004-09-06
CN100372864C (zh) 2008-03-05
CN1863814A (zh) 2006-11-15
IS2740B (is) 2011-06-15
PE20030926A1 (es) 2003-10-29
HRP20040634A2 (en) 2004-10-31
IS7339A (is) 2004-06-28
RU2004125580A (ru) 2006-01-27
AR038165A1 (es) 2004-12-29
YU63004A (sh) 2006-08-17
BRPI0306736B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
ATE408609T1 (de) Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
ATE515500T1 (de) Verfahren zur herstellung von telmisartan
ATA11912002A (de) Verfahren zur herstellung von fälschungssicheren identifikationsmerkmalen
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
DE60327788D1 (de) Verfahren zur herstellung von polytrimethylenterephthalt-fasern
ATE549314T1 (de) Verfahren zur herstellung von 4-aminochinazolinen
ATE308524T1 (de) Verfahren zur herstellung von aripiprazole
ATE315099T1 (de) Verfahren zur herstellung von tagatose
DE50308650D1 (de) Verfahren zur herstellung von cellulosecarbamatformkörpern
DE60330050D1 (de) Verfahren zur herstellung von pyrimidinverbindungen
ATE456569T1 (de) Verfahren zur herstellung von 6-alkyliden- penemderivaten
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
DE602004000126D1 (de) Verfahren zur Herstellung von selbststanzenden Muttern
ATE336478T1 (de) Verfahren zur herstellung von benzophenonen
ATE453619T1 (de) Verfahren zur herstellung von hydroperoxiden
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
DE60210911D1 (de) Verfahren zur Herstellung von dehnungserfassenden Vorrichtungen
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
ATE471941T1 (de) Verfahren zur herstellung von thiazolopyrimidinen
ATE371642T1 (de) Verfahren zur herstellung von 3- methylthiopropanal

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties